Washington Family Magazine : June 2015
8 June 2015 washingtonFAMILY.com ADMINISTRATION CHIEF OPERATING OFFICER Bruce Potter publisher@theFAMILYmagazine.com EDITOR Britni Petersen bpetersen@theFAMILYmagazine.com MANAGING EDITOR Debbie Williams dwilliams@theFAMILYmagazine.com SPECIAL PROJECTS EDITOR Cynda Zurfluh czurfluh@theFAMILYmagazine.com CALENDAR EDITOR Marti Badilla CONTRIBUTING WRITERS Ryan Anderson Bell, Rex Eaton, Jaime Coffey Martinez, Debbie Williams, Cynda Zurfluh ART & PRODUCTION PRODUCTION MANAGER Steven Chi production@theFAMILYmagazine.com GRAPHIC DESIGNER Ashley Jabaly ajabaly@theFAMILYmagazine.com PR/MARKETING DIGITAL MEDIA PRODUCER/SOCIAL MEDIA COORDINATOR Colleen McGrew cmcgrew@theFAMILYmagazine.com ADVERTISING SALES TEAM LEADER Sylvia Witaschek switaschek@theFAMILYmagazine.com ACCOUNT EXECUTIVES Pauline Ray pray@theFAMILYmagazine.com Julie Turco jturco@theFAMILYmagazine.com DISTRIBUTION DISTRIBUTION COORDINATOR Dean McPhee distribution@theFAMILYmagazine.com Washington FAMILY Magazine is published 12 times a year by HPR-Hemlock LLC, and is distributed free of charge throughout Mar yland, Northern Virginia and Washington, D.C. Subscription rates for home delivery are $40 for one year. Correspondence and editorial submissions from our readers are welcomed. We reserve the right to edit, reject or comment on all editorial and advertising material submitted. We are not responsible for the return of any unsolicited materials. The acceptance of advertising by Washington FAMILY Magazine does not constitute an endorsement of the products, ser vices or information. All rights reserved by copyright. © 2015 HPR-Hemlock LLC. Any reproduction of this publication, in whole or in part, is strictly forbidden without expressed written permission. 11260 Roger Bacon Drive, Suite 20, Reston, VA 20190 703-318-1385 • washingtonfAmily.com published by: BAYER, the Bayer Cross and Essure are registered trademarks of Bayer. © 2015 Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, 07981 All rights reserved. PP -250-US -0606 Printed in USA February 2015 Important Safety Information (continued) WARNING: Be sure you are done having children before you undergo the Essure procedure. Essure is a permanent method of birth control. During the procedure: In clinical trials some women experienced mild to moderate pain (9.3%). Your doctor may be unable to place one or both Essure® inserts correctly. Although uncommon, part of an Essure insert may break off or puncture the fallopian tube requiring surgery to repair the puncture. Your doctor may recommend a local anesthetic. Ask your doctor about the risks associated with this type of anesthesia. Immediately following the procedure: In clinical trials some women experienced mild to moderate pain (12.9%) and/or cramping (29.6%), vaginal bleeding (6.8%), and pelvic or back discomfort for a few days. Some women experienced nausea and/or vomiting (10.8%) or fainting. In rare instances, an Essure insert may be expelled from the body. During the Essure Confirmation Test: You will be exposed to very low levels of radiation, as with most x-rays. In rare instances, women may experience spotting and/or infection. Long-term Risks: There are rare reports of chronic pelvic pain in women who have had Essure. In rare instances, an Essure insert may migrate through the fallopian tubes and may require surgery. No birth control method is 100% effective. Women who have Essure are more likely to have an ectopic pregnancy (pregnancy outside the uterus) if they get pregnant. This can be life-threatening. The Essure insert is made of materials that include a nickel-titanium alloy. Patients who are allergic to nickel may have an allergic reaction to the inserts. Symptoms include rash, itching and hives. The safety and effectiveness of Essure has not been established in women under 21 or over 45 years old. Essure inserts do not protect against HIV or other sexually transmitted diseases. Talk to your doctor about Essure and whether it is right for you. You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.